REFERENCES
- Querques G, Kuhn D, Massamba N, Leveziel N, Querques L, Souied EH. Perifoveal exudative vascular anomalous complex. J Fr Ophtalmol. 2011;34(559):e1–4. doi:10.1016/j.jfo.2011.03.002.
- Sacconi R, Freund KB, Yannuzzi LA, et al. The expanded spectrum of perifoveal exudative vascular anomalous complex. Am J Ophthalmol. 2017;184:137–146. doi:10.1016/j.ajo.2017.10.009.
- Mrejen-Uretsky S, Le HM, Nghiem-Buffet S, Tabary S, Quentel G, Cohen SY. Insights into perifoveal exudative vascular anomalous complex. Retina. 2018. doi:10.1097/IAE.0000000000002435.
- Freund KB, Ho IV, Barbazetto IA, et al. Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina. 2008;28:201–211. doi:10.1097/IAE.0b013e3181669504.
- Yannuzzi LA, Negrao S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina. 2001;21:416–434.
- Nagiel A, Sarraf D, Sadda SR, et al. Type 3 neovascularization: evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral domain optical coherence tomography. Retina. 2015;35:638–647. doi:10.1097/IAE.0000000000000488.
- Su D, Lin S, Phasukkijwatana N, et al. An updated staging system of type 3 neovascularization using spectral domain optical coherence tomoGRAPHY. Retina. 2016;36(Suppl 1):S40–S9. doi:10.1097/IAE.0000000000001268.
- Sacconi R, Sarraf D, Garrity S, et al. Nascent type 3 neovascularization in age-related macular degeneration. Ophthalmol Retina. 2018;2:1097–1106. doi:10.1016/j.oret.2018.04.016.
- Gross NE, Aizman A, Brucker A, Klancnik JM Jr., Yannuzzi LA. Nature and risk of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation. Retina. 2005;25:713–718.
- Chang YS, Kim JH, Yoo SJ, Lew YJ, Kim J. Fellow-eye neovascularization in unilateral retinal angiomatous proliferation in a Korean population. Acta Ophthalmol. 2016;94:e49–53. doi:10.1111/aos.12748.
- Rich RM, Rosenfeld PJ, Puliafito CA, et al. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina. 2006;26:495–511. doi:10.1097/01.iae.0000225766.75009.3a.
- Pai SA, Shetty R, Vijayan PB, et al. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol. 2007;143:601–606. doi:10.1016/j.ajo.2006.12.037.
- Charbel Issa P, Holz FG, Scholl HP. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Ophthalmology. 2007;114:1736–1742. doi:10.1016/j.ophtha.2007.03.079.
- Ayachit AG, Sacconi R, Ayachit GS, Joshi S, Querques G. perifoveal exudative vascular anomalous complex-like lesion as a complication of prepapillary arterial loops. Ophthalmic Surg Lasers Imaging Retina. 2018;49:974–978. doi:10.3928/23258160-20181203-11.